Metabolic effects of isradipine in non-insulin-dependent diabetes mellitus (NIDDM) hypertensive patients

Cardiovasc Drugs Ther. 1995 Jun;9(3):459-60. doi: 10.1007/BF00879035.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Antihypertensive Agents / adverse effects
  • Antihypertensive Agents / therapeutic use*
  • Blood Glucose / metabolism
  • Blood Pressure / drug effects
  • Calcium Channel Blockers / adverse effects
  • Calcium Channel Blockers / therapeutic use*
  • Delayed-Action Preparations
  • Diabetes Mellitus, Type 2* / metabolism
  • Female
  • Heart Rate / drug effects
  • Humans
  • Hypertension / drug therapy*
  • Isradipine / adverse effects
  • Isradipine / therapeutic use*
  • Male
  • Middle Aged

Substances

  • Antihypertensive Agents
  • Blood Glucose
  • Calcium Channel Blockers
  • Delayed-Action Preparations
  • Isradipine